You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
SciBase: Capital raise explained
The ongoing capital raise would reduce the financing risks and secures SciBase's financing until early 2025. We expect the raise to succeed. Why? Analyst Antti Luiro comments more in this interview!
Content:
00.00 Intro
00:14 Investment case and revenue growth drivers
02:40 Capital raise package explained
06:11 Why do we believe that the capital raise will succeed?
07:51 Risks?
12:38 Valuation and estimates
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
View all videos